Search the site
Raenaud Tiwari
Associate
Raenaud joined the firm in 2022 after being called to the Ontario Bar and completing his articles at a prominent litigation boutique in downtown Toronto. He received his J.D. from Queen’s University and obtained his Honours Bachelor of Science in Life Sciences and minor in Chemical Biology from McMaster University. During law school, Raenaud participated in the Harold G. Fox Intellectual Property Moot, where his team secured the prize for Best Respondent Factum. He also volunteered at the Queen’s Business Law Clinic, and was an executive on clubs such as the Queen’s Venture Law Society and the South Asian Law Students’ Association.
Education
- B.Sc., McMaster University
- J.D., Queen’s University
Bar Admission
- Ontario, 2022
My recent cases
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,652,442 and 2,771,403 (lenvatinib).
Actions under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,861,480 (trifluridine/tipiracil hydrochloride).
Actions under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,861,480; 2,914,999 and 2,985,006 (trifluridine/tipiracil).
Counsel to respondent trademark owner in expungement proceedings regarding trademark TMA822855. Successfully applied for dismissal of proceeding due to undue and inexcusable delay (2024 FC 579).
Actions under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,851,588 (brexpiprazole).
Actions under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,602,247 (brexpiprazole).
Actions under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,832,157 (brexpiprazole).
More people
.jpg)
.jpg)
.jpg)
%20(1).jpg)
